Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,064.20 +45.81 (+0.91%) Dow
38,225.66 +322.37 (+0.85%) Nasdaq
15,840.96 +235.48 (+1.51%) Bitcoin USD
58,799.56 +1,587.57 (+2.77%) CMC Crypto 200
1,269.78 -0.96 (-0.08%)
AMGN May 2024 290.000 put
| Previous close | 19.86 |
| Open | 19.87 |
| Bid | 15.95 |
| Ask | 18.00 |
| Strike | 290.00 |
| Expiry date | 2024-05-31 |
| Day's range | 19.86 - 19.87 |
| Contract range | N/A |
| Volume | |
| Open interest | 2 |
- Reuters
UPDATE 1-Amgen first-quarter profit dips 1%, revenue rises 22%
Amgen reported a slightly lower first-quarter profit on Thursday, citing higher operating and interest expense from its recent acquisition of rare disease drugmaker Horizon Therapeutics, partially offset by double-digit revenue growth. The biotechnology company's adjusted profit fell 1% to $3.96 per share, which still beat the average analyst estimate of $3.88 per share, according to LSEG data. The results were "essentially in-linish ... although not anything significant for the Street given that it is still early in the year," David Song, portfolio manager of the Tema Obesity & Cardiometabolic ETF said in an email.
ReutersAmgen first-quarter profit dips 1%, revenue rises 22%
(Reuters) -Amgen reported a slightly lower first-quarter profit on Thursday, citing higher operating and interest expense from its recent acquisition of rare disease drugmaker Horizon Therapeutics, partially offset by double-digit revenue growth. The biotechnology company's adjusted profit fell 1% to $3.96 per share, which still beat the average analyst estimate of $3.88 per share, according to LSEG data. The results were "essentially in-linish ... although not anything significant for the Street given that it is still early in the year," David Song, portfolio manager of the Tema Obesity & Cardiometabolic ETF said in an email.
PR NewswireAMGEN REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
Amgen (NASDAQ:AMGN) today announced financial results for the first quarter 2024.
